Paediatric drug use with focus on off-label prescriptions at Swedish hospitals - A nationwide study

Acta Paediatrica, International Journal of Paediatrics

Volumn 101, Issue 7, 2012, Pages 772-778

  Kimland, E ^a,b   Nydert, P ^a   Odlind, V ^b   Bottiger Y ^a   Lindemalm, S ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b MEDICAL PRODUCTS AGENCY   (Sweden)

Author keywords

Child; Drug prescription; Hospital care; Off label; Sweden

Indexed keywords

ADRENALIN; ALLERGEN; CAFFEINE CITRATE; CALCIUM; CARBOHYDRATE; CLOBAZAM; CLONIDINE; COTRIMOXAZOLE; DICLOFENAC; ELECTROLYTE; ERGOCALCIFEROL; FOLIC ACID; GLUCOSE; HEPARIN; KETAMINE; MELATONIN; MIDAZOLAM; MORPHINE; MULTIVITAMIN; PARACETAMOL; PHOSPHATE; PRESCRIPTION DRUG; PROCHLORPERAZINE; PROMETHAZINE; SODIUM CHLORIDE; TECHNETIUM;

ADOLESCENT; ANALGESIA; ARTICLE; CHILD; CHILD NUTRITION; DRUG USE; FEMALE; HUMAN; INFANT; INFECTION; MAJOR CLINICAL STUDY; MALE; NEWBORN; OFF LABEL DRUG USE; PAIN; PEDIATRIC ANESTHESIA; PEDIATRIC HOSPITAL; PEDIATRIC SURGERY; PREMATURITY; PRESCHOOL CHILD; PRESCRIPTION; PRIORITY JOURNAL; SCHOOL CHILD; SWEDEN; TOTAL PARENTERAL NUTRITION;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; DRUG UTILIZATION; FEMALE; HEALTH CARE SURVEYS; HOSPITALS, PEDIATRIC; HUMANS; INFANT; INFANT, NEWBORN; MALE; OFF-LABEL USE; PROSPECTIVE STUDIES; SWEDEN;

EID: 84861808998     PISSN: 08035253     EISSN: 16512227     Source Type: Journal    
DOI: 10.1111/j.1651-2227.2012.02656.x     Document Type: Article

References (34)

1. Di Paolo ER, Stoetter H, Cotting J, Frey P, Gehri M, Beck-Popovic M, et al., Unlicensed and off-label drug use in a Swiss paediatric university hospital. Swiss Med Wkly 2006; 136: 218-22.
2. t Jong GW, Vulto AG, de Hoog M, Schimmel KJ, Tibboel D, van den Anker JN,. A survey of the use of off-label and unlicensed drugs in a Dutch children's hospital. Pediatrics 2001; 108: 1089-93.
3. Santos DB, Clavenna A, Bonati M, Coelho HL,. Off-label and unlicensed drug utilization in hospitalized children in Fortaleza, Brazil. Eur J Clin Pharmacol 2008; 64: 1111-8.
4. Cuzzolin L, Atzei A, Fanos V,. Off-label and unlicensed prescribing for newborns and children in different settings: a review of the literature and a consideration about drug safety. Expert Opin Drug Saf 2006; 5: 703-18.
5. Pandolfini C, Bonati M,. A literature review on off-label drug use in children. Eur J Pediatr 2005; 164: 552-8.
6. Dell'Aera M, Gasbarro AR, Padovano M, Laforgia N, Capodiferro D, Solarino B, et al., Unlicensed and off-label use of medicines at a neonatology clinic in Italy. Pharm World Sci 2007; 29: 361-7.
7. Johnson TN,. The problems in scaling adult drug doses to children. Arch Dis Child 2008; 93: 207-11.
8. Jonville-Bera AP, Bera F, Autret-Leca E,. Are incorrectly used drugs more frequently involved in adverse drug reactions? A prospective study Eur J Clin Pharmacol 2005; 61: 231-6.
9. Turner S, Nunn AJ, Fielding K, Choonara I,. Adverse drug reactions to unlicensed and off-label drugs on paediatric wards: a prospective study. Acta Paediatr 1999; 88: 965-8.
10. European commission. European commission, Regulation (EC) no 1901/2006 of the European Parlament and of the Council of 12 December 2006 on medicinal products for paediatric use and amending Regulation (EEC) No 1768/92, Directive 2001/20/EC, Directive 2001/83/EC and Regulation (EC) No 726/2004. Official J 2006; L378: 1-19. Available at: (accessed on January 16, 2008).
11. European Medicines Agency. CPMP/ICH/2711/99. ICH Topic E 11, Clinical Investigation of Medicinal Products in the Paediatric Population. Available at: http://www.ema.europa.eu.
12. FASS (Swedish Catalogue of Medical Products) [database on the Internet]. Available at: http://www.fass.se.
13. MPA (Medical Product Agency). Available at: http://www.fass.se.
14. Collaborating Centre for Drug Statistics Methodology [database on the Internet]. Available at: http://www.whocc.no.
15. International Classification of Disease (ICD). World Health Organization (WHO); Available at: http://www.who.int/classifications/icd/en/.
16. Health Care registries, EpC. The National Board of Health and Welfare.
17. Lindell-Osuagwu L, Korhonen MJ, Saano S, Helin-Tanninen M, Naaranlahti T, Kokki H,. Off-label and unlicensed drug prescribing in three paediatric wards in Finland and review of the international literature. J Clin Pharm Ther 2009; 34: 277-87.
18. Craig JS, Henderson CR, Magee FA,. The extent of unlicensed and off-label drug use in the paediatric ward of a district general hospital in Northern Ireland. Ir Med J 2001; 94: 237-40.
19. Bajcetic M, Jelisavcic M, Mitrovic J, Divac N, Simeunovic S, Samardzic R, et al., Off label and unlicensed drugs use in paediatric cardiology. Eur J Clin Pharmacol 2005; 61: 775-9.
20. Gavrilov V, Lifshitz M, Levy J, Gorodischer R,. Unlicensed and off-label medication use in a general pediatrics ambulatory hospital unit in Israel. Isr Med Assoc J 2000; 2: 595-7.
21. Pandolfini C, Impicciatore P, Provasi D, Rocchi F, Campi R, Bonati M,. Off-label use of drugs in Italy: a prospective, observational and multicentre study. Acta Paediatr 2002; 91: 339-47.
22. Turner S, Longworth A, Nunn AJ, Choonara I,. Unlicensed and off label drug use in paediatric wards: prospective study. BMJ 1998; 316: 343-5.
23. O'Donnell CP, Stone RJ, Morley CJ,. Unlicensed and off-label drug use in an Australian neonatal intensive care unit. Pediatrics 2002; 110: e52.
24. Conroy S, Peden V,. Unlicensed and off label analgesic use in paediatric pain management. Paediatr Anaesth 2001; 11: 431-6.
25. t Jong GW, van der Linden PD, Bakker EM, van der Lely N, Eland IA, Stricker BH, et al., Unlicensed and off-label drug use in a paediatric ward of a general hospital in the Netherlands. Eur J Clin Pharmacol 2002; 58: 293-7.
26. Turner S, Gill A, Nunn T, Hewitt B, Choonara I,. Use of "off-label" and unlicensed drugs in paediatric intensive care unit. Lancet 1996; 347: 549-50.
27. European Medicines Agency (EMA), Medicines for children, Priority list of off-patent medicines.
28. Cras A, Conscience MA, Rajzbaum G, Lillo-Le Louet A, Lopez N, Tersen I, et al., Off-label prescribing in a French hospital. Pharm World Sci 2007; 29: 97-100.
29. Kimland E, Bergman U, Lindemalm S, Bottiger Y,. Drug related problems and off-label drug treatment in children as seen at a drug information centre. Eur J Pediatr 2007; 166: 527-32.
30. Horen B, Montastruc JL, Lapeyre-Mestre M,. Adverse drug reactions and off-label drug use in paediatric outpatients. Br J Clin Pharmacol 2002; 54: 665-70.
31. Clarkson A, Ingleby E, Choonara I, Bryan P, Arlett P,. A novel scheme for the reporting of adverse drug reactions. Arch Dis Child 2001; 84: 337-9.
32. Ufer M, Kimland E, Bergman U,. Adverse drug reactions and off-label prescribing for paediatric outpatients: a one-year survey of spontaneous reports in Sweden. Pharmacoepidemiol Drug Saf 2004; 13: 147-52.
33. Alvarez-Requejo A, Carvajal A, Begaud B, Moride Y, Vega T, Arias LH,. Under-reporting of adverse drug reactions. Estimate based on a spontaneous reporting scheme and a sentinel system. Eur J Clin Pharmacol 1998; 54: 483-8.
34. Backstrom M, Mjorndal T, Dahlqvist R,. Under-reporting of serious adverse drug reactions in Sweden. Pharmacoepidemiol Drug Saf 2004; 13: 483-7.